NeuroSave is a clinical-stage medical device company dedicated to preventing and treating ischemic brain injury caused by surgery, cardiac arrest, stroke or trauma. Our goal is to rapidly deliver the benefits of therapeutic hypothermia to the brain while protecting the body from the negative effects of cooling. To achieve cerebral cooling, NeuroSave therapy circulates cold fluid in the aerodigestive tract and cools the blood in the arteries traveling to the brain. This results in rapid brain-targeted cooling. In both animal and human trials, NeuroSave technology demonstrated cerebral cooling that is far faster than any available non-surgical approach and can create a significant difference between the temperature of body's core and brain.
Location: United States, California, San Francisco
Mentions in press and media 2